Beam stock forecast.

Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...(See BEAM stock forecast on TipRanks) iHeartMedia (IHRT) Let’s switch stations now and tune into something entirely different. iHeartMedia is one of the U.S.’s most prominent audio companies ...The average Beam Therapeutics stock price prediction forecasts a potential upside of 52.06% from the current BEAM share price of $27.95. What is BEAM's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BEAM ) forecast ROE is N/A , which is considered weak . Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.

This is hardly the only bullish review for Beam, although the company’s 6 recent analyst reviews do have an even split between Buys and Holds – making the consensus rating a Moderate Buy. BEEM shares have an average target of $29.50 and a current trading price of $15.09, suggesting ~95% upside going forward. (See BEAM stock forecast on ...

Tangshan Factory Hot Rolled Steel Profile H Beam I Beam with Stock Price, Find Details about Steel H Beam, H Beam from Tangshan Factory Hot Rolled Steel ...Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 2.00, with a high estimate of 8.00 and a low estimate of 0.50. The ...

Nov 15, 2023 · Earnings vs Market: BEEM is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: BEEM is expected to become profitable in the next 3 years. Revenue vs Market: BEEM's revenue (24.5% per year) is forecast to grow faster than the US market (7.7% per year). Feb 1, 2023 · (See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ... Get the latest Infibeam Avenues Ltd (INFIBEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Every so often in Dave Eggers’s The Circle, a disturbing novel about the future as imagined by tech companies, the characters talk about going “retinal.” Eggers never explains what that means, though some readers might assume it’s a more ad...The average Beam Therapeutics stock price prediction forecasts a potential upside of 52.06% from the current BEAM share price of $27.95. What is BEAM's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BEAM ) forecast ROE is N/A , which is considered weak .

Beam Global has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off last year's report dates. Learn more on BEEM's earnings history.

(See BEAM stock forecast on TipRanks) iHeartMedia (IHRT) Let’s switch stations now and tune into something entirely different. iHeartMedia is one of the U.S.’s most prominent audio companies ...

Mar 5, 2023 · Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ... Hold candidate since Nov 13, 2023 Gain 20.46% PDF. The Beam Global stock price gained 20.46% on the last trading day (Tuesday, 14th Nov 2023), rising from $6.06 to $7.30. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days.People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.TTOO. T2 Biosystems, Inc. Common Stock. $0.56 +0.1067 +23.54%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market ...Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsMar 15, 2021 · Based on those assumptions, my modeling says Aeva could do about $10 in earnings per share by 2030. A simple 20X multiple on that implies a long-term potential price target here of $200. The AEVA ...

Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Dec 1, 2023 · According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $48.80 with a high price target of $105.00 and a low price target of $20.00. Learn more on ... AADI Stock 12 Months Forecast. $33.00. (599.15% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Aadi Bioscience in the last 3 months. The average price target is $33.00 with a high forecast of $36.00 and a low forecast of $30.00. The average price target represents a 599.15% change from the last price of $4.72.Based on short-term price targets offered by 16 analysts, the average price target for Alibaba comes to $126.50. The forecasts range from a low of $100.00 to a high of $150.00. The average price ...BEAM : Suntory Holdings Completes Acquisition of Beam Inc. 2014: BU BEAM : Jim Beam To Host "Distillery Days" In Clermont 2014: PR Beam : Announces Intention to Delist and Deregister Common Stock, 8 5/8% Debentures Due 2021 and 7 …

The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46. (NASDAQ: SGMO) Sangamo Therapeutics's forecast annual revenue growth rate of -28.5% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.51%.

Feb 1, 2023 · (See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ... TTOO. T2 Biosystems, Inc. Common Stock. $0.56 +0.1067 +23.54%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market ... Aug 29, 2023 · BEAM stock, belonging to Beam Therapeutics Inc, has shown promising performance on August 29, 2023, according to data from CNN Money. The 15 analysts offering 12-month price forecasts for BEAM stock have a median target of $56.00, with a high estimate of $105.00 and a low estimate of $32.00. Beam Global provides sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media. It develops, patents, designs, engineers and ...Nov 29, 2023 · According to 3 analysts, the average rating for BEEM stock is "Strong Buy." The 12-month stock price forecast is $26.67, which is an increase of 343.02% from the latest price. Beam Price Live Data. The live Beam price today is $0.164128 USD with a 24-hour trading volume of $6,003,743 USD. We update our BEAM to USD price in real-time. Beam is up 214.10% in the last 24 hours. The current CoinMarketCap ranking is #654, with a live market cap of $24,315,976 USD. It has a circulating supply of 148,152,520 BEAM coins and a ...One 10 foot long 3.00″ x 0.17″ x 2.33″ standard steel I-beam from MetalsDepot.com costs $76.90. They have larger sizes available, such as the 10 foot long 8.00″ x 0.27″ x 4.00″ standard steel I-beam, which costs $248.40. Depending on size, ...Nov 29, 2023 · According to 3 stock analysts, the average 12-month stock price forecast for Beam Global stock is $26.67, which predicts an increase of 343.02%. The lowest target is $25 and the highest is $30. On average, analysts rate Beam Global stock as a strong buy. Chronic organ damage is the leading cause of death in adults with SCD. Beam is advancing multiple base editing programs for sickle cell disease, led by Beam-101, an ex vivo cell therapy in which cells are collected from a patient, edited, and then infused back into the patient. To create space for the edited cells to take hold in the bone ...

Meanwhile, Cathie Wood has been adding more BEAM shares to the ARKG ETF. During January, she purchased 163,838 shares. The ETF now hold 2,126,439 shares in total, currently worth ~$92.4 million ...

Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.

According to 4 analyst offering 12-month price targets in the last 3 months, Beam Therapeutics has an average price target of $70.25 with a high of $105.00 and a low of $37.00. Below is a summary ...Beam Therapeutics Stock Forecast Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 0.2% based on the past 3 years of stock performance. Beam Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%See Beam Therapeutics Inc. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.The first Wood-backed stock we’ll look at is Beam Therapeutics, ... Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast)Find the latest Beam Global (BEEM) stock quote, history, news and other vital information to help you with your stock trading and investing.January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...Technology Services. Industry. Packaged Software. No executives to display. Corporate headquarters. --, --. Find real-time PLTR - Palantir Technologies Inc stock quotes, company profile, news and ...Beam Global provides sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media. It develops, patents, designs, engineers and ...

Nov 15, 2023 · Earnings vs Market: BEEM is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: BEEM is expected to become profitable in the next 3 years. Revenue vs Market: BEEM's revenue (24.5% per year) is forecast to grow faster than the US market (7.7% per year). Get The Latest CRWD Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content S&P 500 4,594.63 (+0.59%)Aug 13, 2023 · The Vanguard Group, Inc. is the second largest shareholder owning 8.3% of common stock, and Arch Venture Partners, L.P. holds about 7.1% of the company stock. Furthermore, CEO John Evans is the ... Find real-time DDOG - Datadog Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $0.32: Annual revenue (last year) $1.7B: Annual profit (last ...Instagram:https://instagram. standard property management feetoday's biggest stock gainersshopify price increasenvidia stock purchase Average 51.83 75.87% Upside Low 19.00 -35.53% Downside High 95.00 222.36% Upside Broker Rating Beam Therapeutics Inc. currently has an average brokerage recommendation (ABR) of 1.86 on a scale of... popular gold stocksfacet wealth review TTOO. T2 Biosystems, Inc. Common Stock. $0.56 +0.1067 +23.54%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market ...Nov 18, 2023 · Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years. otc brokerage firms Based on 5 Buys and 4 Holds, the analyst consensus rates the stock a Moderate Buy. Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast) CareDx, Inc (CDNA) The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition.Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing ...